A study investigating 141 head and neck squamous cell carcinomas reported worse clinical outcomes for patients with truncating TP53 mutations compared to patients with wildtype TP53, whilst missense TP53 mutations did not influence prognosis23. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.